Results 11 to 20 of about 4,157,974 (295)
Managing Synchronous Liver Metastases in Colorectal Cancer [PDF]
Indian Journal of Surgical Oncology, 2018 The most common site of blood-borne metastases from colorectal cancers (CRC) is the liver. Resection of (liver) metastases is a part of standard treatment of metastatic colorectal cancer. Hepatic resection is the first-line treatment of liver metastases, with 5-year survival rates between 25 and 58%.
ÇETİN, BÜLENT +3 more
openaire +5 more sources
Therapeutics and Clinical Risk Management, 2008 Tamana Walia, J Fernando Quevedo, Timothy J Hobday, Gary Croghan, Aminah JatoiDivision of Medical Oncology, Rochester, MN, USABackground: Do colorectal cancer patients with hyperbilirubinemia and liver metastases benefit from chemotherapy?Methods/Results:
Tamana Walia +4 more
doaj +1 more source
Immune mediated and direct killing of colorectal cancer by reovirus [PDF]
, 2012 Colorectal cancer remains the second most prevalent cancer in the world. Novel treatment strategies are necessary, especially for the treatment of metastatic disease.
Adair, Robert Allan
core +6 more sources
Colorectal Cancer, Liver Metastases and Biotherapies [PDF]
Biomedicines, 2021 (1) Background: colorectal cancer (CRC) is one of the deadliest causes of death by cancer worldwide. Its first main metastatic diffusion spreads to the liver. Different mechanisms such as the epithelial–mesenchymal transition and angiogenesis are the characteristics of this invasion.
Osei-Bordom, Daniel-Clement +2 more
openaire +4 more sources
Predictive Markers of Colorectal Cancer Liver Metastases
Future Oncology, 2011 Liver metastases are the most common site of distant failure after curative resection of colorectal cancer and a source of significant cancer-related morbidity and mortality. Currently, imaging and conventional histopathologic features, such as T-stage and N-stage, are used by clinicians to inform prognosis and guide adjuvant treatment to reduce the ...
Anand, Govindarajan, Philip B, Paty
openaire +3 more sources
Identificació de nous marcadors moleculars en metàstasi hepàtica de càncer colorectal [PDF]
, 2010 [cat] L’objectiu d’aquest treball és la identificació i caracterització de les principals alteracions en metàstasi hepàtica (MH) de càncer colorectal (CCR) tant a nivell d’expressió gènica com de metilació de l’ADN.
Padullés Mosella, Laura
core +6 more sources
Colorectal cancer liver metastases: mechanism and therapy. [PDF]
Front ImmunolColorectal cancer (CRC) is a leading cause of cancer mortality worldwide, with liver metastasis representing the principal cause of death in CRC patients. Current primary treatment options for colorectal cancer liver metastases (CRLM) encompass chemotherapy, radiotherapy, targeted therapy, and immunotherapy. However, the survival rate for CRLM patients
Liu S +6 more
europepmc +3 more sources
Treatment of liver metastases from colorectal cancer.
The Netherlands journal of medicine, 2006 In recent years several new local as well as systemic treatment options have become available for patients with advanced colorectal cancer. A survey among Dutch hospitals revealed considerable differences in the use of diagnostic and therapeutic strategies.
Tol, J., Punt, C.J.A.
openaire +4 more sources
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) [PDF]
, 2012 The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Hammerstingl, Renate Maria +6 more
core +1 more source
Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis
Frontiers in Oncology, 2022 Colorectal cancer is one common digestive malignancy, and the most common approach of blood metastasis of colorectal cancer is through the portal vein system to the liver.
Yun Wang +3 more
doaj +1 more source